Paul Mason

Paul Mason is Director of Innovation Policy at Innovate UK, the UK’s innovation agency. The role gives him a key role in determining the future of technology across the nation.

It could have been different. An enthusiastic jazz player in his teens, he almost became a professional musician. But decided instead to study chemistry. The income prospects for a scientist were more reliable than for a freelance jazz player, he says. “Career choice has to be a compromise between what you love, what you do well and what people are prepared to pay for.”

Paul acknowledges the huge educational opportunities he has experienced, first at his local comprehensive then at Balliol College, Oxford. “The quality of staff at school and university, and the time they invested in their students’ education, was huge,” he says.

Graduating in 1984, he rejected merchant banking and took up a full-time job at Courtaulds, which had sponsored his degree. It was there that he first used a networked computer, which the company had installed for its researchers to share their work and exchange reports.

During 25 years in the chemical industry, Paul worked on a wide range of technologies and markets. At Courtaulds, he worked on industrial and apparel fibres, high-tech and packaging films, separation technologies, polymers for a range of applications including LCD polarising filters and sunglasses frames, dyeing technologies, anti-fouling coatings for shipping, and in many other areas including spells in Europe, the US and Japan. He went on to hold change management, manufacturing, and commercial roles in Akzo Nobel and CVC/Acordis.

In 2007, Paul became Head of Development at the newly-formed Technology Strategy Board, which later morphed into Innovate UK. He is responsible for corporate strategy and the programmes that support its development and implementation.

Over the years, Paul has set up and launched national innovation programmes in areas such as agriculture and food, stratified medicine, disease diagnosis and creative industries. In many of these, the UK is world-leading, he says.

Not every idea that gains funding can be expected to succeed. “We’ve invested in some individual projects that went nowhere, but that would happen in industry and with venture capital too – but the programmes overall have been successful.” In innovation the UK is punching well above its weight in many areas, he says, including in offshore renewable energy, creative and digital industries, automotive, aerospace, advanced manufacturing and service industries, and in pharmaceutical and medical industries. For instance, in advanced therapies “about 38% of all European clinical trials are being conducted in the UK.”

Professor Sir Martin Sweeting

Professor Sir Martin Sweeting has been fascinated by telecommunications since childhood, and a love of science fiction, particularly the writings of Arthur C Clarke, fostered his enthusiasm for technology.

At school his best subjects were English, French and Latin, but in those days it was hard to combine sciences and arts. So he did A’levels in chemistry, maths and his favourite, physics, going on to gain a degree in electronic and electrical engineering at the University of Surrey, and a PhD.

In 1985, Sir Martin set up Surrey Satellite Technology with about £100 and four employees. The company pioneered rapid-response, low-cost and highly capable small satellites, on which much of our modern life depends. In 2008, SST was sold to Airbus Defence & Space for £50m, but Sir Martin is still executive chairman. The company now has 400 professional staff, annual revenues of more than $100m and total export sales in excess of $1bn to 25 countries. Among its many focuses is clearing up the increasing amount of space debris, which represents a significant threat to the next generation of satellites.

Sir Martin was awarded an OBE in 2002 and won the 2008 Arthur C Clarke Lifetime Achievement Award. In 2016, he was made an Honorary Fellow of the Royal Aeronautical Society and listed by Sunday Times as one of the 500 most influential UK citizens.

Professor Jim McLaughlin OBE

Professor James Mclaughlin OBE is working on portable / wearable diagnostic devices that will transform personal healthcare with automatic monitoring of heart rates, blood sugar levels and the like, reporting the results and triggering alerts over mobile . He worked on the team that developed the first external defibrillator and is now the director of the Nanotechnology and Integrated Bioengineering Centre at the University of Ulster. He holds over 30 patents including for the world’s best-selling disposable medical electrode. He has successfully co-founded a set of spin-off companies while raising over £100 million of research funding.

Dr Martin Read CBE

Dr Martin Read CBE is credited with the transformation of Logica, from the archetypal British 20th century software house with a headcount of 3,000 largely centred in the UK, to a 21st century dynamic enterprise with a headcount in excess of 40,000 based in over 40 countries. Martin followed the familiar path from grammar-school boy in Basingstoke to Oxford DPhil in Physics via Cambridge. He then deviated from a classic scientific career path and commenced his employment in shipping container logistics, where he applied his intellect to operations and strategic planning and worked abroad.

After a spell in the marine business of International Paint, his commercial and management skills were honed working for Lord Weinstock at GEC, before he was headhunted to Logica. After 14 years in the software industry, Dr Read again switched track and has been in high demand for a diverse portfolio of chair, non-executive director and senior advisory roles in industry and Government. His advice to the next generation is to begin their careers in well-managed organisations and to gain early experience in sales and working abroad .